Clamor has risen around India & South Africa’s proposal seeking the waiver of Intellectual Property Rights (IPR) for easier access to COVID-19 medicines. But what choices do nations have if the nego...

Dr Rashmi Banga, Senior Economic Affairs Officer, UNCTAD, states that to move towards global vaccine equity, it is important for the governments to declare vaccines as a public good and not allow phar...

Prof Manoj Pant, Director, IIFT, argues that for once, the IPR waiver on COVID vaccines should be taken as a non-political necessity in response to a once-in-a-decade event. The long term political op...